XML 92 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNT POLICIES (Tables)
12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Schedule Of Inventories, Net
Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or market. Inventories consisted of the following:
 
 
December 31,
 
2013
 
2012
 
(In thousands)
Finished goods
$
123,786

 
$
102,401

Work in process
47,403

 
40,067

Raw materials
35,730

 
29,338

Total inventories, net
$
206,919

 
$
171,806

Schedule Of Property, Plant And Equipment Balances And Corresponding Lives
Property, plant and equipment balances and corresponding lives were as follows:  
 
December 31,
 
 
 
2013
 
2012
 
Useful Lives
 
(In thousands)
 
 
Land
$
3,022

 
$
2,768

  
 
Buildings and building improvements
15,377

 
7,908

  
5-40 years
Leasehold improvements
42,900

 
46,240

  
1-20 years
Machinery and production equipment
86,192

 
85,721

  
3-20 years
Surgical instrument kits
30,352

 
26,231

 
4-5 years
Information systems and hardware
51,171

 
42,145

 
1-7 years
Furniture, fixtures, and office equipment
16,363

 
15,692

 
1-15 years
Construction-in-progress
112,130

 
90,243

  
 
Total
357,507

 
316,948

  
 
Less: Accumulated depreciation
(157,197
)
 
(139,050
)
 
 
Property, plant and equipment, net
$
200,310

 
$
177,898

  
 
Schedule Of Changes In Carrying Amount Of Goodwill
Changes in the carrying amount of goodwill in 2013 and 2012 were as follows:
 
U.S.
Neurosurgery
 
U.S.
Instruments
 
U.S.
Extremities
 
U.S.
Spine
and
Other
 
International
 
Total
 
(In thousands)
Goodwill, gross
$
94,312

 
$
57,514

 
$
60,353

 
$
56,219

 
$
25,669

 
$
294,067

Accumulated impairment losses

 

 

 

 

 

Goodwill at December 31, 2012
$
94,312

 
$
57,514

 
$
60,353

 
$
56,219

 
$
25,669

 
$
294,067

Tarsus Medical, Inc. acquisition

 

 
180

 

 

 
180

Goodwill impairment charge

 

 

 
(46,738
)
 

 
(46,738
)
Foreign currency translation
853

 
519

 
546

 
106

 
231

 
2,255

Balance, December 31, 2013
$
95,165

 
$
58,033

 
$
61,079

 
$
9,587

 
$
25,900

 
$
249,764

Components Of Company's Identifiable Intangible Assets
The components of the Company's identifiable intangible assets were as follows:
 
December 31, 2013
 
December 31, 2012
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in Thousands)
Completed technology
12 years
 
$
81,238

 
$
(45,343
)
 
$
35,895

 
12 years
 
$
75,692

 
$
(38,402
)
 
$
37,290

Customer relationships
12 years
 
146,627

 
(79,624
)
 
67,003

 
12 years
 
147,690

 
(70,005
)
 
77,685

Trademarks/brand names
31 years
 
33,703

 
(15,648
)
 
18,055

 
31 years
 
33,807

 
(15,034
)
 
18,773

Trademarks/brand names
Indefinite
 
48,484

 

 
48,484

 
Indefinite
 
48,484

 

 
48,484

Supplier relationships
27 years
 
34,721

 
(9,305
)
 
25,416

 
27 years
 
34,721

 
(7,817
)
 
26,904

All other (1)
5 years
 
4,251

 
(1,941
)
 
2,310

 
4 years
 
4,519

 
(1,388
)
 
3,131

 
 
 
$
349,024

 
$
(151,861
)
 
$
197,163

 
 
 
$
344,913

 
$
(132,646
)
 
$
212,267

 
(1)
At December 31, 2013 and 2012, all other included IPR&D of $1.4 million and $1.7 million, respectively, which was indefinite-lived.
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
The medical device excise tax applies to sales beginning January 1, 2013; therefore, only 2013 financial results were affected by this change. Accordingly, the 2013 results included herein have been revised to reflect the retrospective application of the change in accounting principle had the new method been in effect that year, as follows:

Consolidated Statements of Operations:
 
Year ended December 31, 2013
 
Originally
 
 
 
As
 
Reported
 
Adjustments
 
Adjusted
 
(In thousands, except per share amounts)
Cost of goods sold
$
334,085

 
$
(7,040
)
 
$
327,045

Selling, general and administrative
394,250

 
13,552

 
407,802

Income tax expense (benefit)
(7,813
)
 
(2,422
)
 
(10,235
)
Net income (loss)
(16,977
)
 
(4,090
)
 
(21,067
)
Basic net income (loss) per common share
$
(0.60
)
 


 
$
(0.74
)
Diluted net income (loss) per common share
(0.60
)
 


 
(0.74
)

Consolidated Statements of Comprehensive Income:
 
Year ended December 31, 2013
 
Originally
 
 
 
As
 
Reported
 
Adjustments
 
Adjusted
 
(In thousands, except per share amounts)
Net income (loss)
$
(16,977
)
 
$
(4,090
)
 
$
(21,067
)
Comprehensive income (loss)
(11,253
)
 
(4,090
)
 
(15,343
)


Consolidated Balance Sheets:
 
December 31, 2013
 
Originally
 
 
 
As
 
Reported
 
Adjustments
 
Adjusted
 
(In thousands)
Inventories
$
213,431

 
$
(6,512
)
 
$
206,919

Deferred tax assets - current
46,300

 
2,316

 
48,616

Prepaid expenses and other current assets
26,752

 
106

 
26,858

Retained earnings
285,046

 
(4,090
)
 
280,956



Consolidated Statements of Cash Flows:
 
Year ended December 31, 2013
 
Originally
 
 
 
As
 
Reported
 
Adjustments
 
Adjusted
 
(In thousands)
Net income (loss)
$
(16,977
)
 
$
(4,090
)
 
$
(21,067
)
Deferred income tax provision (benefit)
(10,829
)
 
(2,316
)
 
(13,145
)
Inventories
(42,017
)
 
6,512

 
(35,505
)
Prepaid and other current assets
4,929

 
(106
)
 
4,823